Interestingly, while both bacterial neuraminidase and T. cruzi sialidase activate only MMP-2, the mammalian sialidase Neu-3, specific for SA α2,3 recognition observed in human prostate cancer models [69], is able to modulate both MMP-2 and MMP-9. This evidence concerns the gene NEU3 and prostate carcinoma.